BIB logo

BIB Overview

Profile

Name:

ProShares Ultra Nasdaq Biotechnology

Assets under management:

$64 M

Expense ratio:

0.95%

Inception date:

April 9, 2010

Website:

http://www.proshares.com

Last ex-dividend date:

December 23, 2024

Next ex-dividend date:

N/A

Description:

BIB ETF is an exchange-traded fund that aims to provide leveraged exposure to the performance of the biotechnology sector. It seeks to amplify returns by investing in biotech stocks, making it suitable for investors looking for higher risk and potential rewards in this industry.

Top holdings

Name
Weight
NASDAQ Biotechnology Index SWAP UBS AG
17.17 %
NASDAQ Biotechnology Index SWAP Bank of America NA
15.90 %
NASDAQ Bio Index SWAP BNP Paribas
8.68 %
TREASURY BILL
6.86 %
Net Other Assets (Liabilities)
5.32 %
NASDAQ Biotechnology Index SWAP Citibank NA
5.05 %
NASDAQ Biotechnology Index SWAP Goldman Sachs International
4.18 %
GILD logo
Gilead Sciences(GILD)
3.06 %
NASDAQ Biotechnology Index SWAP Societe Generale
3.01 %
AMGN logo
Amgen(AMGN)
2.76 %
VRTX logo
Vertex Pharmaceuticals Incorporated(VRTX)
2.67 %
REGN logo
Regeneron Pharmaceuticals(REGN)
2.26 %
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC
2.16 %
AZN logo
AstraZeneca(AZN)
1.29 %
ALNY logo
Alnylam Pharmaceuticals(ALNY)
0.96 %
ARGX logo
argenx SE(ARGX)
0.62 %
BIIB logo
Biogen(BIIB)
0.61 %
SNY logo
Sanofi(SNY)
0.49 %
SMMT logo
Summit Therapeutics(SMMT)
0.49 %
UTHR logo
United Therapeutics(UTHR)
0.48 %
ILMN logo
Illumina(ILMN)
0.44 %
RPRX logo
Royalty Pharma(RPRX)
0.44 %
INSM logo
Insmed Incorporated(INSM)
0.43 %
MRNA logo
Moderna(MRNA)
0.41 %
ITCI logo
Intra-Cellular Therapies(ITCI)
0.41 %
INCY logo
Incyte(INCY)
0.41 %
VTRS logo
Viatris(VTRS)
0.40 %
BMRN logo
BioMarin Pharmaceutical(BMRN)
0.39 %
NBIX logo
Neurocrine Biosciences(NBIX)
0.36 %
BNTX logo
BioNTech SE(BNTX)
0.35 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$55.50
BIB price is $55.50

Price All-time High

$111.49
BIB price is currently -50.22% below its historical high of $111.49

Price Most Recent Change

+0.91%
BIB price was up +0.91% on Feb 25, 2025

Price YTD Change

+9.55%
BIB price is up +9.55% since January 1st

Price 1-Year Change

-8.45%
BIB price is down -8.45% year-on-year

Price 3-Year Change

-3.6%
BIB price is down -3.6% over the past 3 years

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.57
BIB beta is 1.57

200-day SMA

$59.74
BIB price is currently -7.09% below its 200-day simple moving average

14-day RSI

51.82
BIB 14-day relative strength index is 51.82

30-day Relative Volume

1.14
BIB 30-day relative volume is 1.14

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Last Paid Dividend

$0.40
BIB last dividend was $0.40 per share, with an ex-dividend date of December 23, 2024

TTM Dividend Per Share

$0.81
BIB TTM dividend per share is $0.81

TTM Dividend Per Share 1-Year Change

+2019.79%
BIB TTM dividend per share is up +2019.79% year-on-year

TTM Dividend Per Share 3-Year Change

-
BIB TTM dividend per share 3-year change is unknown

Dividend yield

TTM Dividend Yield

1.47%
BIB TTM dividend yield is 1.47%

TTM Dividend Yield 1-Year Change

+2350%
BIB TTM dividend yield is up +2350% year-on-year

Top holdings

Name
Weight
NASDAQ Biotechnology Index SWAP UBS AG
17.17 %
NASDAQ Biotechnology Index SWAP Bank of America NA
15.90 %
NASDAQ Bio Index SWAP BNP Paribas
8.68 %
TREASURY BILL
6.86 %
Net Other Assets (Liabilities)
5.32 %
NASDAQ Biotechnology Index SWAP Citibank NA
5.05 %
NASDAQ Biotechnology Index SWAP Goldman Sachs International
4.18 %
GILD logo
Gilead Sciences(GILD)
3.06 %
NASDAQ Biotechnology Index SWAP Societe Generale
3.01 %
AMGN logo
Amgen(AMGN)
2.76 %
VRTX logo
Vertex Pharmaceuticals Incorporated(VRTX)
2.67 %
REGN logo
Regeneron Pharmaceuticals(REGN)
2.26 %
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC
2.16 %
AZN logo
AstraZeneca(AZN)
1.29 %
ALNY logo
Alnylam Pharmaceuticals(ALNY)
0.96 %
ARGX logo
argenx SE(ARGX)
0.62 %
BIIB logo
Biogen(BIIB)
0.61 %
SNY logo
Sanofi(SNY)
0.49 %
SMMT logo
Summit Therapeutics(SMMT)
0.49 %
UTHR logo
United Therapeutics(UTHR)
0.48 %
ILMN logo
Illumina(ILMN)
0.44 %
RPRX logo
Royalty Pharma(RPRX)
0.44 %
INSM logo
Insmed Incorporated(INSM)
0.43 %
MRNA logo
Moderna(MRNA)
0.41 %
ITCI logo
Intra-Cellular Therapies(ITCI)
0.41 %
INCY logo
Incyte(INCY)
0.41 %
VTRS logo
Viatris(VTRS)
0.40 %
BMRN logo
BioMarin Pharmaceutical(BMRN)
0.39 %
NBIX logo
Neurocrine Biosciences(NBIX)
0.36 %
BNTX logo
BioNTech SE(BNTX)
0.35 %

Analyst ratings

FAQ

  • What is BIB?
  • Does BIB pay dividends?
  • What stocks are in BIB?
  • What is the current assets under management for BIB?
  • What is BIB average volume?
  • What is BIB expense ratio?
  • What is BIB inception date?

What is BIB?

BIB ETF is an exchange-traded fund that aims to provide leveraged exposure to the performance of the biotechnology sector. It seeks to amplify returns by investing in biotech stocks, making it suitable for investors looking for higher risk and potential rewards in this industry.

Does BIB pay dividends?

Yes, the ProShares Ultra Nasdaq Biotechnology does pays dividends, with the most recent payment being $0.40 per share. The last ex-dividend date was on December 23, 2024, and the next ex-dividend date has not been announced yet

What stocks are in BIB?

As of today, ProShares Ultra Nasdaq Biotechnology inlcudes 274 holdings, with 262 of them being companies from 14 different countries and 1 sectors. The most weighted holdings are NASDAQ Biotechnology Index SWAP UBS AG (17.17%), NASDAQ Biotechnology Index SWAP Bank of America NA (15.9%) and NASDAQ Bio Index SWAP BNP Paribas (8.68%)

What is the current assets under management for BIB?

Assets under management of ProShares Ultra Nasdaq Biotechnology is $64 M

What is BIB average volume?

Average volume of ProShares Ultra Nasdaq Biotechnology is $10 K

What is BIB expense ratio?

Expense ratio of ProShares Ultra Nasdaq Biotechnology is 0.95%

What is BIB inception date?

Inception date of ProShares Ultra Nasdaq Biotechnology is April 9, 2010